-1.21%
16.12%
15.00%
15.56%
-0.98%
-13.49%
42.50%
AI Spotlight on STMN
Company Description
Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide.It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss.The company offers dental implant systems for tissue and bone level; titanium, titanium alloy, ceramic, and mini dental implant systems; and guided and non-guided surgical instruments, as well as implant-borne prosthetics.
It provides ceramic healing and screw retained abutments; intraoral scanning solutions; 3D printers; milling machines; and prevention products.In addition, it offers biomaterials, bone substitutes, membranes, biologics, and soft tissue management and oral healing products; digital solutions for dental labs, dentists, and centralized milling centers, as well as materials, third party systems, and guided surgery; surgical instruments comprising surgical and modular cassettes, guided instruments, implant maintenance products, bone block fixation sets, bonerings, titanium pin sets, and other cassettes; and edentulous, pro arch fixed, prosthetic, and mini implant solutions for edentulous patients.Further, it provides esthetic restorations that include ceramic implant monotypes, ceramic implants, abutments, biologics, and other solutions; and Emdogain for wound healing.
Further, it offers systems Clear Correct aligners; and training and education services to its customers.The company provides its products to general dentists, specialists, and dental technicians and laboratories, as well as corporate customers, such as distributors, hospitals, universities, and dental service organizations in approximately 100 countries through a network of distribution subsidiaries and partners.Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.
Market Data
| Last Price | 131.1 |
| Change Percentage | -1.21% |
| Open | 132.7 |
| Previous Close | 132.7 |
| Market Cap ( Millions) | 20903 |
| Volume | 116378 |
| Year High | 151.5 |
| Year Low | 103.75 |
| M A 50 | 117.74 |
| M A 200 | 119.77 |
Financial Ratios
| FCF Yield | 1.64% |
| Dividend Yield | 0.65% |
| ROE | 14.23% |
| Debt / Equity | 23.05% |
| Net Debt / EBIDTA | 18.15% |
| Price To Book | 10.61 |
| Price Earnings Ratio | 77.18 |
| Price To FCF | 61.12 |
| Price To sales | 8.47 |
| EV / EBITDA | 31.8 |
News
- Sep -06 - Straumann Holding (SAUHY) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
- Aug -14 - Straumann stock rallies on upbeat results
- Apr -06 - BELIMO Holding (VTX:BEAN) shareholders have earned a 13% CAGR over the last five years
- Apr -01 - Investors in Autoneum Holding (VTX:AUTN) have seen respectable returns of 40% over the past five years
- Mar -19 - Straumann Holding AG's (VTX:STMN) Stock Has Fared Decently: Is the Market Following Strong Financials?
- Jan -18 - Estimating The Intrinsic Value Of Straumann Holding AG (VTX:STMN)
- Dec -06 - Institutions along with retail investors who hold considerable shares inStraumann Holding AG (VTX:STMN) come under pressure; lose 3.2% of holdings value
- Nov -07 - Is There Now An Opportunity In Straumann Holding AG (VTX:STMN)?
- Oct -31 - UPDATE 2-Dental company Straumann's results boosted by a recovery in Asia
- Oct -24 - Investors Shouldn't Overlook The Favourable Returns On Capital At Straumann Holding (VTX:STMN)
- Oct -10 - Straumann Holding AG's (VTX:STMN) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
- Aug -12 - The Returns At Bell Food Group (VTX:BELL) Aren't Growing
- Aug -10 - Estimating The Fair Value Of Straumann Holding AG (VTX:STMN)
- Jul -11 - Straumann Holding AG (SAUHF) Is a Great Choice for 'Trend' Investors, Here's Why
- Jun -22 - Straumann Holding AG (SAUHF) Upgraded to Buy: Here's Why
- Jun -06 - Slowing Rates Of Return At Forbo Holding (VTX:FORN) Leave Little Room For Excitement
- May -29 - What Is Straumann Holding AG's (VTX:STMN) Share Price Doing?
- May -01 - Is Straumann Holding AG's (VTX:STMN) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Business Breakdown
Expected Mid-Term Growth
Segment n°1 -> EMEA
Expected Growth : 9.5 %
What the company do ?
EMEA (Europe, Middle East, and Africa) is a geographic segment of Straumann Holding AG, a global leader in implant and dental care solutions.
Why we expect these perspectives ?
EMEA's 9.5% growth in Straumann Holding AG is driven by increasing demand for dental implants, strategic partnerships, and expansion into emerging markets. Strong sales in Germany, UK, and France, coupled with growing adoption of digital dentistry solutions, contribute to the region's growth. Additionally, investments in marketing and sales initiatives, as well as a strong distribution network, support the segment's growth momentum.
Segment n°2 -> North America
Expected Growth : 10.5 %
What the company do ?
North America is a region for Straumann Holding AG, a global leader in implant and dental tissue regeneration, covering the US, Canada, and other countries.
Why we expect these perspectives ?
Straumann Holding AG's 10.5% growth in North America is driven by increasing demand for dental implants, rising adoption of digital dentistry, and strategic partnerships with dental clinics and laboratories. Additionally, the region's aging population and growing awareness of oral health contribute to the growth.
Segment n°3 -> Asia Pacific
Expected Growth : 11.0 %
What the company do ?
The Asia Pacific segment of Straumann Holding AG includes countries such as Australia, China, India, Japan, and South Korea, among others, where the company operates its dental implant and biomaterials business.
Why we expect these perspectives ?
Strong demand for premium dental implants and orthodontic solutions in Asia Pacific, driven by rising middle-class population, increasing awareness of oral healthcare, and growing adoption of digital dentistry. Additionally, Straumann's strategic partnerships and investments in the region, such as its partnership with T-Plus in Taiwan, have contributed to the 11.0% growth.
Segment n°4 -> Latin America
Expected Growth : 8.5 %
What the company do ?
Latin America is a region comprising 20 countries in Central and South America, where Straumann Holding AG operates, offering dental implant and orthodontic solutions.
Why we expect these perspectives ?
Straumann Holding AG's 8.5% growth in Latin America is driven by increasing demand for dental implants, rising middle-class disposable income, and growing awareness of oral health. Additionally, the region's large and growing elderly population, coupled with a high prevalence of tooth loss, fuels demand for Straumann's products.
Straumann Holding Ag Products
| Product Range | What is it ? |
|---|---|
| Dental Implants | Straumann's dental implants are designed to replace missing teeth and provide a natural-looking and feeling smile. |
| CARES Digital Dentistry | CARES is a digital dentistry system that offers a comprehensive solution for dental labs and clinics, including CAD/CAM, 3D printing, and milling. |
| Bone and Tissue Regeneration | Straumann's bone and tissue regeneration products are designed to promote bone growth and tissue regeneration in dental implant procedures. |
| Prosthetic Components | Straumann's prosthetic components, including abutments and crowns, are designed to work in harmony with their dental implants. |
| Digital Dentures | Straumann's digital dentures are designed to provide a precise and comfortable fit, using advanced digital technology. |
Straumann Holding AG's Porter Forces
Threat Of Substitutes
Straumann Holding AG operates in the dental implant industry, where substitutes are limited. However, the company faces competition from other dental implant manufacturers, which could be considered substitutes.
Bargaining Power Of Customers
Dental clinics and hospitals, Straumann's customers, have limited bargaining power due to the company's strong brand reputation and high-quality products.
Bargaining Power Of Suppliers
Straumann Holding AG has a diversified supplier base, which reduces the bargaining power of individual suppliers. The company's strong financial position also gives it negotiating power.
Threat Of New Entrants
The dental implant industry has high barriers to entry, including regulatory hurdles and significant R&D investments. This limits the threat of new entrants.
Intensity Of Rivalry
The dental implant industry is highly competitive, with several established players competing for market share. Straumann Holding AG faces intense rivalry from companies like Nobel Biocare and Zimmer Biomet.
Capital Structure
| Value | |
|---|---|
| Debt Weight | 12.48% |
| Debt Cost | 5.58% |
| Equity Weight | 87.52% |
| Equity Cost | 9.90% |
| WACC | 9.36% |
| Leverage | 14.27% |
Straumann Holding AG : Quality Control
Straumann Holding AG passed 6 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
| Company | Rational |
|---|---|
| EL.PA | EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in North America, Europe, Latin America, Asia, Oceania, and Africa. It operates in five segments: Wholesale, Retail, Lenses … |
| DIM.PA | Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a … |
| COLO-B.CO | Coloplast A/S develops and sells intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Interventional Urology, Voice … |
| ROG.SW | Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products … |
| SOON.SW | Sonova Holding AG designs, develops, manufactures, and distributes hearing care solutions for adults and children. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The company offers wireless … |
Peers Metrics
DCF BETA
Expected Cash-Flows
Scoring Insights
Peers Group Analysis
🥇
Roche
A-Score
1-Year Total Return ->
🥈
EssilorLuxottica
A-Score
1-Year Total Return ->
🥉
Coloplast
A-Score
1-Year Total Return ->
4
Sonova
A-Score
1-Year Total Return ->
5
Straumann
A-Score
1-Year Total Return ->
6
